Honing Indications for Endocrine Therapy in ER-Low Early Breast Cancer

(MedPage Today) -- Omission of endocrine therapy in estrogen receptor (ER)-low early breast cancer had a significant association with worse survival, particularly in patients with residual disease after neoadjuvant chemotherapy (NAC), a large retrospective...